A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Current effective treatment methods for interleukin-23/T helper type 17 cells pathway in rheumatologic and autoimmune diseases
2020
Demiroglu Bilim University Florence Nightingale Transplantation Journal
The interleukin 23/T helper 17 pathway is involved in the mechanism of many autoimmune and rheumatologic diseases. The inhibition of inflammation by blocking receptors and cytokines in this pathway has become the main target for the development of novel therapeutic agents. Studies on these therapeutic agents are promising. Studies on these therapeutic agents are promising. Keywords: Interleukin 17, Interleukin 23, rheumatologic disease, T helper 17 cell. Current effective treatment methods for
doi:10.5606/fng.transplantasyon.2018.007
fatcat:xsvyne7p35hutj6kn6wiaamrau